Literature DB >> 3325017

Outcome of singleton infants delivered vaginally or by caesarean section at 23 to 28 weeks' gestation.

V Y Yu1, H L Loke, W Szymonowicz.   

Abstract

The survival and impairment rates of 276 inborn singleton infants of 23-28 weeks' gestation were reported according to route of delivery and mode of presentation. The Caesarean section rate was 29% overall, ranging from 13% at 25 weeks to 46% at 28 weeks. In the vertex group, no significant difference in survival or impairment rate was found between Caesarean and vaginal births. In the non-vertex group, Caesarean births had a similar survival rate but a significantly lower impairment rate compared to vaginal births. For Caesarean births, no significant difference in survival or impairment rate was found between vertex and non-vertex groups. In contrast, for vaginal births, the mode of presentation was important: the non-vertex group had a significantly lower survival rate and higher impairment rate compared to the vertex group. We found no evidence to support the use of Caesarean section in extremely preterm infants with vertex presentation, except for recognized maternal or fetal indications. The findings in the non-vertex group indicated that there is a definite need for a randomized clinical trial to investigate the possible benefits of Caesarean section in extremely preterm infants with non-vertex presentation.

Entities:  

Mesh:

Year:  1987        PMID: 3325017     DOI: 10.1111/j.1479-828x.1987.tb00985.x

Source DB:  PubMed          Journal:  Aust N Z J Obstet Gynaecol        ISSN: 0004-8666            Impact factor:   2.100


  2 in total

1.  Effect of cesarean section on outcome in high- and low-risk very preterm infants.

Authors:  J Dietl; H Arnold; H Mentzel; H A Hirsch
Journal:  Arch Gynecol Obstet       Date:  1989       Impact factor: 2.344

2.  Delivery of very premature infants: does the caesarean section rate relate to mortality, morbidity, or long-term outcome?

Authors:  J Dietl; H Arnold; G Haas; H Mentzel; B Pietsch-Breitfeld; H A Hirsch
Journal:  Arch Gynecol Obstet       Date:  1991       Impact factor: 2.344

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.